VRIII is for patients who can't eat, or whose glucose can't be managed with subcutaneous insulin while unwell. DKA uses a fixed-rate infusion instead.
Continue long-acting (basal) insulin during a VRIII.
Act now
- 1
Prescribe the insulin syringe and a glucose-containing substrate fluid together on the local VRIII chart.
- 2
Choose the starting scale (standard, reduced if insulin-sensitive, increased if insulin-resistant).
Assess
- Indication: nil by mouth for more than one missed meal, vomiting, or hyperglycaemia not controlled with subcutaneous insulin.
- Diabetes type, usual regimen, U&E (K⁺), ketones if type 1.
Investigations
- Capillary glucose hourly; U&E at least daily (watch K⁺ and Na⁺); ketones if type 1 and glucose over 12 mmol/L.
Manage
- Target glucose 6–10 mmol/L (4–12 acceptable).
- Don't stop or slow the substrate fluid to treat high glucose — change the insulin rate instead.
- Glucose under 4 mmol/L: treat the hypo; restart the VRIII within 20 minutes once glucose is over 4, on a lower scale.
- Glucose above target on two consecutive readings despite a working line: move to the next scale up.
- Stopping: once eating and drinking, give the usual subcutaneous insulin with a meal and stop the VRIII 30–60 minutes later.
Escalate when
- Persistently out of range, ketones 3 mmol/L or above (treat as DKA), recurrent hypos, or K⁺ under 3.5: senior and diabetes team.
Doses and prescribing
Soluble insulin (Actrapid or Humulin S)
50 units in 50 mL 0.9% sodium chloride = 1 unit/mL.
Substrate fluid per local VRIII chart — e.g. 0.45% sodium chloride with 5% glucose and 0.15% potassium chloride at a fixed rate based on fluid needs.
Check the BNF and your local formulary before prescribing.
Written to current guidance · sources checked 14 Nov 2026. We watch NICE for updates weekly.
Sources (3)
- JBDS-IP 09 — Use of variable rate intravenous insulin infusion in medical inpatientschecked 14 Nov 2026
- JBDS-IP 01 — Hospital management of hypoglycaemia in adults with diabetesVersion 1 Jan 2023, checked 14 Nov 2026
- BNF — check doses, cautions and renal adjustmentchecked 14 Nov 2026
Reviewed by Aboodee Alhasso, MPharm MRCPharm IP on 14 Nov 2026
For healthcare professionals, as an aid to clinical judgement — not a substitute for it. Follow your local policy and ask a senior when in doubt.